Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by PeterMacd2on Jun 16, 2019 2:49pm
115 Views
Post# 29830380

RE:RE:RE:RE:RE:Thoughts on Rec. 2.0 Regulations and where we are at

RE:RE:RE:RE:RE:Thoughts on Rec. 2.0 Regulations and where we are atI know what you are saying Treehugger, and I'm not in favour of GMOs either.  I avoid them when I can. But the reality is that products from Cannabis sativa are now industrial-scale food/drug commodities, like alcohol, tobacco, and other smokable, edible or drinkable products derived from plants. It's a logical consequence of becoming legalized, as now the big agro-industry players and smaller biotech cos. can become involved on the production side, just like big pharma and big alcohol are on the branding, marketing and distribution side.  I don't like it, but that's the reality.  It's going to be hard for ambitious growers like APH and others to compete and succeed if they don't adopt the promising high-yielding varieties (assuming those become commercially available). And since I'm here to make money on APH (my largest single holding by far), I want them to succeed.  Although I'd like to think there will always be a niche for small speciality "organic" growers who use only "non-GMO" hemp plants, just as there still are for all other crop plants. But that niche is likely to be mostly confined to small-scale producers selling at farmers markets  - not the fate for APH I sincerely hope!!  
Bullboard Posts